Piramal Pharma Solutions Achieves a Notable Net Promoter Score
Piramal Pharma Solutions recently celebrated a significant achievement with a Net Promoter Score (NPS) of 55, which substantially surpasses the industry average. This score is a clear indicator of the company's unwavering commitment to stakeholder satisfaction and operational excellence.
Validation of the NPS Score
The validation of this score was conducted by DNV, a recognized third-party provider. Their involvement ensures the accuracy and accountability of the survey results, reflecting the Company’s steadfast focus on meeting and exceeding the expectations of its customers and partners.
Customer Loyalty Metrics Explained
Net Promoter Score is widely used as a reliable measure of customer loyalty, gauging how likely customers are to recommend a product or service to their peers. Piramal Pharma Solutions undertakes annual surveys to gather insights from clients, allowing them to better understand their performance and adapt to changing client needs.
Insights Driving Business Strategy
These annual surveys, coordinated by the Company’s Customer Centricity team, play an essential role in shaping business strategies. The findings from the NPS surveys are meticulously analyzed, which aids in developing actionable plans that enhance service delivery and client engagement.
Performance Comparison with Competitors
This year, the score achieved by Piramal Pharma Solutions stands in stark contrast to the often lower scores reported by various competitor CDMOs, asserting its position as a trusted leader in the pharmaceutical industry.
Commitment to Stakeholders
The notable NPS can be attributed to the Company's relentless dedication to patients, customers, and consumers. This commitment is evident in every aspect of their operations as the organization has embedded stakeholder-centric policies into their culture.
Piramal Pharma Solutions places great importance on understanding and addressing stakeholder needs, which is integral to their operational goals. This approach not only enhances communication but also fosters collaboration at all levels, strengthening partnerships and bolstering long-term client relations.
Aiming Beyond Satisfaction
The organization’s mission extends beyond merely achieving customer satisfaction; they strive for customer delight. By keeping stakeholder needs at the forefront, Piramal Pharma Solutions exceeds client expectations, delivering exceptional value.
Future Directions
“As we progress, the insights from this year’s NPS survey will steer our strategic initiatives, allowing us to augment client engagement and operational effectiveness,” stated Peter DeYoung, CEO of Piramal Global Pharma. “Our ongoing commitment to enhancing our services and processes ensures we deliver maximum value to customers, consumers, and patients globally.”
The Customer Centricity team safeguards the integrity of NPS data by coordinating with various departments throughout the assurance process. The results are presented to the Board of Directors, who review them before publication in the annual Sustainability Report, further emphasizing Piramal Pharma Solutions' dedication to transparency and accountability.
About Piramal Pharma Solutions
Piramal Pharma Solutions (PPS) operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive solutions throughout the drug lifecycle. With a globally integrated facility network across North America, Europe, and Asia, the company offers a wide array of services, including drug discovery solutions, pharmaceutical development services, and clinical supply management. Additionally, they specialize in manufacturing highly potent APIs, sterile fill/finish, and biologics, including vaccines and gene therapies.
Expansion and Future Offerings
Moving forward, Piramal Pharma Solutions will continue to expand its offerings, dedicated to enhancing drug development processes and ensuring client needs are met effectively.
Company Overview
Piramal Pharma Limited (PPL), underscoring its position in the market, provides a variety of differentiated products and services through its global development and manufacturing network, serving over 100 countries. Within its portfolio, PPL includes Piramal Pharma Solutions and several other healthcare segments, showcasing a commitment to improving health outcomes worldwide.
Frequently Asked Questions
What is the Net Promoter Score achieved by Piramal Pharma Solutions?
Piramal Pharma Solutions achieved a remarkable Net Promoter Score (NPS) of 55.
Who validated the Net Promoter Score?
The NPS score was validated by DNV, a third-party assurance provider.
What does a higher NPS signify?
A higher NPS indicates greater customer loyalty and satisfaction, showing that customers are likely to recommend the company’s services.
What is the focus of Piramal Pharma Solutions?
The Company prioritizes customer and stakeholder centricity, aiming to exceed expectations and enhance partnerships.
What services does Piramal Pharma Solutions offer?
Piramal Pharma Solutions provides a wide range of services, including drug manufacturing, process development, and biologics services.
